Targeting NRAS via miR-1304-5p or farnesyltransferase inhibition confers sensitivity to ALK inhibitors in ALK-mutant neuroblastoma
Article in Nature Communications (April 2024)
The most recent citing publications are shown below. View all 41 publications that cite this research output on Dimensions.
Article in Nature Communications (April 2024)
Article in Advanced Functional Materials (March 2024)
Article in Pharmacological Reviews (March 2024)